Omron (OTCMKTS:OMRNY) Raised to Hold at Zacks Research

Omron (OTCMKTS:OMRNY) was upgraded by equities researchers at Zacks Research from a “strong sell” rating to a “hold” rating in a research report issued on Monday,Zacks.com reports.

Separately, Jefferies Financial Group cut shares of Omron from a “buy” rating to a “hold” rating in a research report on Tuesday, June 16th. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company has an average rating of “Hold”.

Omron Stock Performance

Shares of OMRNY opened at $43.24 on Monday. The company has a market cap of $8.50 billion, a PE ratio of 41.18, a price-to-earnings-growth ratio of 0.63 and a beta of 1.14. The company has a current ratio of 1.83, a quick ratio of 1.41 and a debt-to-equity ratio of 0.08. The stock has a 50-day moving average price of $35.87 and a 200-day moving average price of $33.00. Omron has a 12-month low of $23.23 and a 12-month high of $43.48.

About Omron

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.